-PAK
Department of Genome Sciences, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan,1 Department of Biochemistry, University of California, Riverside, California 925212
Received 9 June 2003/ Returned for modification 29 July 2003/ Accepted 24 September 2003
| ABSTRACT |
|---|
|
|
|---|
-PAK and the nonreceptor type of protein tyrosine kinase Syk are known to be activated when the cells are exposed to osmotic stress. The purpose of the present study was to examine whether Pak2 and Syk functionally cooperate in cellular signaling. Cotransfection studies revealed that Pak2 associates with Syk in COS cells. The constitutively active form of Cdc42 increases the association of Pak2 with Syk. Pak2 coexpressed with an inactive form of Cdc42 or kinase-inactive Pak2 interacts to a lesser extent with Syk, suggesting that Pak2-Syk association is enhanced by Pak2 activation. Interaction with Pak2 enhances the intrinsic kinase activity of Syk. This is supported by in vitro studies showing that Pak2 phosphorylates and activates Syk. Treatment of cells with sorbitol to induce hyperosmolarity results in the translocation of Pak2 and Syk to the region surrounding the nucleus and in dramatic enhancement of their association. Furthermore, cotransfection of Pak2 and Syk leads to the activation of c-Jun N-terminal kinase (JNK) under hyperosmotic conditions. Pak2 short interfering RNA suppresses sorbitol-mediated activation of endogenous Syk and JNK, thus identifying a novel pathway for JNK activation by Cdc42. These results demonstrate that Pak2 and Syk positively cooperate to regulate cellular responses to stress. | INTRODUCTION |
|---|
|
|
|---|
-PAK), Pak2 (
-PAK or PAK I), and Pak3 (ß-PAK) (3, 15). Pak family protein kinases contain a highly conserved kinase domain and an N-terminal regulatory domain consisting of proline-rich regions and the Cdc42/Rac binding and autoinhibitory domains. A variety of receptors generate signals that can activate Pak family protein kinases via distinct mechanisms. Association of the GTP-bound form of Cdc42/Rac reverses an autoinhibitory intramolecular interaction inducing enzymatic activation and autophosphorylation of Pak family protein kinases. Pak2 is activated in response to hyperosmolarity, irradiation, UV light, and DNA-damaging chemotherapeutic drugs such as cytosine ß-D-arabinofuranoside and cis-platinum(II)diammine dichloride (cisplatin) (24, 25). The activation of Pak2 in response to irradiation or cytosine ß-D-arabinofuranoside is dependent on protein tyrosine kinases (PTKs) and phosphatidylinositol 3-kinase (PI 3-kinase) activity. Cleavage of Pak2 by caspase during Fas ligand-induced apoptosis results in the generation of an active 34-kDa C-terminal fragment of Pak2 that mediates morphological and biochemical changes seen in apoptosis (18, 28, 38). Caspase-mediated proteolytic activation of Pak2 is also observed in the cells stimulated with tumor necrosis factor alpha or C2 ceramide. These findings indicate that Pak2 is a proapoptotic effector. In contrast, Pak2 associates with the Nef protein of human immunodeficiency virus and is required for Nef-mediated antiapoptotic signaling (23, 39). Expression of wild-type (WT) Pak2 induces cytostasis in COS-7 and 293T cells, whereas kinase-inactive mutants of Pak2 do not alter cell division (7). Therefore, Pak2 seems to be involved in both cell death and survival pathways. This is supported by a study by Jakobi et al. with a cell line containing stably transfected Pak2 (11).
The nonreceptor type of PTK Syk is widely expressed in hematopoietic cells. Syk is essential for lymphocyte development and is critical for B-cell receptor or Fc receptor-mediated cell activation or integrin-mediated signaling (8, 21, 31, 37). Recent findings reveal that Syk is also expressed in endothelial and epithelial cells and has tumor-suppressive activity in breast cancer cells (4, 40). Induction of Syk results in the suppression of tumor growth and metastasis formation. Syk is composed of a C-terminal kinase domain and tandem N-terminal Src homology 2 (SH2) domains that bind to the phosphorylated immunoreceptor tyrosine-based activating motif (ITAM) of the immune receptor. Conformational changes induced by binding to phosphorylated ITAM and autophosphorylation increase the enzymatic activity of Syk (14, 17). Phosphorylation of tyrosines in the linker region, which separates the SH2 and kinase domains, creates docking sites for other signaling molecules to propagate the downstream signals (6, 13). Similar to the immune receptor stimulation, it was found that oxidative stress and osmotic stress induce the activation of Syk in avian B cells (34).
Pak2 interacts with nonreceptor PTK c-Abl (26). Tyrosine phosphorylation of Pak2 by c-Abl results in the suppression of Pak2 activity and causes accumulation and stabilization of Pak2 by inhibiting protein turnover through the proteasome degradation pathway. The experiments reported here have demonstrated that Pak2 complexes with another member of the nonreceptor type of PTK Syk. This association is enhanced by the activation of Pak2. Moreover, the association of Pak2 with Syk stimulates the kinase activity of Syk. In vitro, Pak2 phosphorylates Syk and stimulates Syk activity. Treatment of cells with sorbitol increases the formation of the Pak2-Syk complex, translocates both kinases from cytosol to the region surrounding the nucleus, and enhances Syk kinase activity. Furthermore, Pak2 and Syk functionally cooperate to activate the downstream c-Jun N-terminal kinase (JNK) in osmotic stress-mediated cellular signaling.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-tubulin were purchased from Sigma (St. Louis, Mo.). Antiphosphotyrosine (anti-pTyr) MAb (4G10), anti-JNK antibody, and anti-Syk MAb were obtained from Upstate Biotechnology (Lake Placid, N.Y.). Antihemagglutinin epitope (anti-HA) (Y-11), anti-Syk, and anti-Pak2/
-PAK antibodies were from Santa Cruz Biotechnology (Santa Cruz, Calif.). Anti-phospho-SAPK/JNK, anti-phospho-Syk (Tyr525/526), and anti-Syk antibodies were from Cell Signaling Technology (Beverly, Mass.). FuGENE 6 transfection reagent was from Roche Molecular Biochemicals (Indianapolis, Ind.). The HA-tagged WT Pak2, HA-Pak2 K278R (kinase inactive), HA-Pak2 T402A (dominant negative), and HA-Cdc42L61 (constitutively active) and HA-Cdc42N17 (constitutively inactive) (provided by J. S. Gutkind, National Institutes of Health, Bethesda, Md.) cDNAs were subcloned into the expression vector pcDNA3.1+ (7, 26). Flag-Cdc42L61 cDNA was generated by PCR. Human Syk cDNA (a gift from B. Mueller-Hilke, Deutsches RheumaForschungs-Zentrum, Berlin, Germany) was subcloned into pApuro expression vector. The Flag-tagged kinase-inactive form of human Syk cDNA was created by replacement of Lys402 by Arg (K402R) by using a PCR-based method. The cDNA of CAKß/Pyk2 (a gift from T. Sasaki, Sapporo Medical University, Sapporo, Japan) was subcloned into pSVL expression vector. The expression constructs pSVL-Lyn and pApuro-T7-Btk were kindly provided by R. P. Siraganian (NIH) and T. Kurosaki (Kansai Medical School, Osaka, Japan), respectively. [
-32P]ATP from NEN Life Science Products (Boston, Mass.) and Val5-angiotensin II from Calbiochem (San Diego, Calif.) were used for in vitro studies. Glutathione S-transferase (GST)-Cdc42 was expressed in Escherichia coli and purified as described previously (10). Sorbitol was purchased from Wako (Osaka, Japan), and 30% hydrogen peroxide was from Santoku (Tokyo, Japan). Cell culture and transient transfection. COS-7 cells were maintained as monolayer cultures in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum and 100 U of penicillin per ml at 37°C. For transient transfection, 6 µl of FuGENE 6 reagent and 2 to 3 µg of cDNA were added to 105 of COS-7 cells seeded in six-well plate, according to the manufacturer's instructions. The amount of transfected cDNA was normalized by the empty vector. In some experiments, cells were incubated with Dulbecco's modified Eagle's medium containing 400 mM sorbitol for 30 min or with 100 µM of H2O2 for 10 min at 37°C. Ramos B cells were maintained in RPMI 1640 medium (Sigma) supplemented with 10% heat-inactivated fetal bovine serum and 100 U of penicillin per ml at 37°C. Ramos B cells expressing simian virus 40 T antigen (Ramos-T cells) were kindly provided by H. Band (Harvard Medical School, Boston, Mass.) and were maintained in the same manner as the parental Ramos B cells. For transient transfection, 10 µg of cDNA was transfected into 107 Ramos-T cells by electroporation (310 V, 950 µF). At 48 h after transfection, cells were utilized for the experiments.
Immunoprecipitation and immunoblotting. At 48 h after transfection, cells were washed twice with ice-cold phosphate-buffered saline (PBS) and solubilized in lysis buffer (1% Nonidet P-40, 50 mM Tris [pH 7.4], 150 mM NaCl, 10 mM EDTA, 1 mM NaF, 1 mM Na3VO4, and protease inhibitors [1 mM phenylmethylsulfonyl fluoride and 2 µg of aprotinin per ml]) (29, 30). The cell lysates were precleared by centrifugation, and the resultant supernatants were incubated with 1 µg of each primary antibody prebound to protein A-agarose. Aliquots from the first centrifugation are referred to as detergent-soluble lysate. After incubation for 1 h at 4°C, the beads were washed four times with lysis buffer. The immunoprecipitated proteins were eluted by heat treatment at 100°C for 5 min in 2x sample buffer, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and electrophoretically transferred to polyvinylidene difluoride membranes (Millipore, Bedford, Mass.). The membranes were blocked with 5% milk in TBST (25 mM Tris [pH 8.0], 150 mM NaCl, and 0.1% Tween 20) for 1 h at room temperature. The blots were incubated with the indicated primary antibodies for 1 h at 4°C. The membranes were washed four times with TBST and incubated with horseradish peroxidase-conjugated secondary antibodies for 30 min at room temperature. After extensive washing with TBST, proteins were visualized by enhanced chemiluminescence (Perkin-Elmer Life Science, Boston, Mass.). For preparation of total cell lysates, cells were washed twice with PBS and directly analyzed by SDS-PAGE after addition of 2x sample buffer. Densitometric analysis of immunoblotting was performed with NIH Image software.
In vitro protein kinase assay.
The washed anti-Syk immunoprecipitates from the differentially transfected cells were incubated in 40 µl of kinase buffer (30 mM HEPES [pH 7.5], 10 mM MgCl2, 2 mM MnCl2, 4 µM ATP, 4 µCi of [
-32P]ATP) and 10 µg of the substrate histone H2B for the indicated times at room temperature (32). Reactions were terminated by heat treatment at 100°C for 5 min in 2x sample buffer, and the proteins were separated by SDS-PAGE. The gels were treated with 1 N KOH for 1 h at 56°C to remove phosphoserine and most of the phosphothreonine. After gel drying, radiolabeled proteins were visualized by autoradiography.
Expression and purification of Syk from insect cells. Syk cDNA was subcloned into the baculovirus expression vector pAcG2T by PCR, using the 5' primer GGATCCATGGCAGACAGTG (underlining indicates the BamHI site) and the 3' primer GAATTCTTAATTAACCACATCGTAGTAG (the EcoRI site is underlined). The PCR product obtained with Pfu DNA polymerase was subcloned into the BamHI (5') and EcoRI (3') sites of pAcG2T (BD Biosciences, Lexington, Ky.) to make Syk in frame with the upstream GST tag. Transfection of insect cells (TN5B-4) and establishment of the recombinant virus were performed with the BaculoGold Transfection kit (BD Biosciences), and overexpression clones were identified. GST-Syk was purified on glutathione-Sepharose 4B (Amersham, Piscataway, N.J.) and eluted with glutathione.
Phosphorylation of Syk and Pak2 in vitro.
GST-Pak2 was obtained by expression of the cDNA in insect cells (TN5B-4) and purified by binding to glutathione-Sepharose 4B. GST-Pak2 was eluted with glutathione, and Pak2 was obtained by cleavage with thrombin as described previously (10). Cdc42 was preloaded with 0.18 mM GTP
S prior to addition of Pak2 (10). Phosphorylation was carried out in 30-µl reaction mixtures containing GST-Syk (0.5 µg) and Pak2 (0.5 to 1.0 µg) in 20 mM Tris (pH 7.4)-5 mM MnCl2-5 mM MgCl2-30 mM 2-mercaptoethanol with 0.2 mM [
-32P]ATP (specific activity, 2,000 to 4,000 cpm/pmol) and 2 µg of leupeptin and aprotinin per ml. Incubation was at 30°C for 30 min. Reactions were terminated by the addition of 5 µl of 100 mM ATP and SDS sample buffer and analyzed by SDS-PAGE on 10% gels. The radiolabeled proteins were detected by autoradiography with X-ray film or a PhosphorImager (Molecular Dynamics, Sunnyvale, Calif.). The 32P incorporated was quantified by counting proteins excised from the gel in a liquid scintillation counter.
To determine the protein kinase activity of Syk, reactions were carried out as described above except that Val5-angiotensin II (1 mM) and bovine serum albumin (0.2 mg/ml) were added. After termination of the reaction with 5 µl of 100 mM ATP, an aliquot (3 to 5 µl) of each sample was analyzed by thin-layer electrophoresis and an aliquot of 20 µl was analyzed by precipitation on Whatman P81 phosphocellulose filter paper as described previously (36). 32P incorporation into Syk precipitated in the filter paper was quantified by liquid scintillation counting. 32P incorporation when analyzed by thin-layer electrophoresis was quantified with the ImageQuant software of the PhosphorImager.
Phosphoamino acid analysis.
GST-Syk and Pak2 phosphorylated with [
-32P]ATP were analyzed by SDS-PAGE as described above. Phosphoamino acid analysis was carried out on phosphorylated proteins excised from the gel as described previously (35).
Immunofluorescence microscopy. COS-7 cells transiently transfected with different cDNAs were fixed with 4% paraformaldehyde in PBS for 10 min. Cells were washed twice with PBS, permeabilized with 0.2% Triton X-100 in PBS for 10 min, washed three times with PBS, and blocked with 3% bovine serum albumin in PBS, all at room temperature. For double staining, cells were primed with anti-HA MAb and rabbit polyclonal anti-Syk antibody for 1 h at room temperature, washed three times with 0.5% Triton X-100 in PBS, and then incubated with secondary antibody (Cy3-labeled goat anti-mouse immunoglobulin G or fluorescein isothiocyanate-labeled goat anti-rabbit immunoglobulin G) for 30 min. The cells were washed as described above, mounted by using a SlowFade antifade kit (Molecular Probes, Eugene, Oreg.), and analyzed by confocal microscopy with LSM 5 Pascal and LSM 510 META instruments (Carl Zeiss, Jena, Germany) (20).
RNA interference. Two sets of synthetic oligonucleotides for the sense and antisense target sequences of the human Pak2-coding sequences including bp 17 to 35 and 472 to 490 with stem-loop sequence to form the small hairpin RNA (5'-GATCCGCTGGAAGATAAGCCTCCAGTTCAAGAGACTGGAGGCTTATCTTCCAGTTTTTTGGAAA-3' and 5'-AGCTTTTCCAAAAAACTGGAAGATAAGCCTCCAGTCTCTTGAACTGGAGGCTTATCTTCCAGCG-3' [bp 17 to 35] and 5'-GATCCGTGCCAAGGGAACAGAAGCATTCAAGAGATGCTTCTGTTCCCTTGGCATTTTTTGGAAA-3' and 5'-AGCTTTTCCAAAAAATGCCAAGGGAACAGAAGCATCTCTTGAATGCTTCTGTTCCCTTGGCACG-3' [bp 472 to 490]) were phosphorylated with T4 kinase (Takara, Tokyo, Japan), annealed, and ligated into BamHI- and HindIII-cleaved backbone of pSilencer 2.1-U6 (Ambion, Austin, Tex.). Both sequences are specific for Pak2. Ten micrograms of the empty vector, pSilencer-Pak2 short interfering RNA (siRNA) (bp 17 to 35), or pSilencer-Pak2 siRNA (bp 472 to 490) was transiently transfected to Ramos-T cells (107) by electroporation (310 V, 950 µF). At 48 h after transfection, cells were utilized for the experiments.
| RESULTS |
|---|
|
|
|---|
|
Cotransfection of Pak2 with Syk elicited slight tyrosine phosphorylation of K278R (Fig. 1, top panel). Tyrosine phosphorylation of WT Pak2 was observed only when the membrane was exposed for longer times (data not shown).
The dominant-negative form of Cdc42 inhibits the association of Pak2 with Syk. The serine/threonine kinase activity of Pak family protein kinases is stimulated by binding of activated GTP bound to Cdc42/Rac (3). To examine the functional interaction between Pak2 and Syk, the cDNAs of HA-tagged WT Pak2 and Syk were cotransfected into COS-7 cells along with either constitutively active Cdc42L61 or inactive Cdc42N17 (Fig. 2). The expression of Cdc42L61 increased the association of Pak2 with Syk, as shown in Fig. 1. On the other hand, expression of inactive Cdc42N17 blocked the coprecipitation of Syk with Pak2 (Fig. 2, lane 4). It is suggested that overexpression of the dominant-negative form of Cdc42 inhibited the activation of Pak2 by endogenous Cdc42 and the subsequent interaction with Syk (Fig. 2, lane 2). The amounts of Syk protein expressed in cells transfected with different cDNAs were similar (Fig. 2, third panel). To confirm that the increase in the coprecipitation of Syk with HA-Pak2 was not due to the same epitope tag on Cdc42, we tested Cdc42L61 with a different epitope tag. As shown (Fig. 2, lane 5), cotransfection with Flag-tagged Cdc42L61 also resulted in a similar increase in the coprecipitation of Syk with Pak2. These findings suggested that Cdc42 functionally regulates the association of Pak2 with Syk in vivo.
|
|
Phosphorylation and activation of Syk by Pak2 in vitro.
The association of Pak2 and Syk, with the resultant enhancement of autophosphorylation and activity of Syk when Syk was coexpressed with Pak2 and Cdc42, suggested that Syk could be a substrate for Pak2. To examine this, purified GST-Syk expressed in insect cells was incubated with purified Pak2 and [
-32P]ATP in the presence of Mg2+ and Mn2+. Phosphorylation of GST-Syk was increased 1.8-fold when phosphorylation was by Pak2 activated with Cdc42 (GTP
S) (Fig. 4A). As expected, phosphoamino acid analysis of autophosphorylated Syk showed that the phosphorylation was exclusively on tyrosine (Fig. 4B). There was little effect on phosphorylation with inactive Pak2. When activated Pak2 was added to the assay mixture, there was additional phosphorylation of Syk on both serine and tyrosine. Quantification of the data showed that the phosphotyrosine/phosphoserine ratio decreased fivefold with activated Pak2. Taken together, the data indicated that there was a substantial increase in tyrosine phosphorylation when Syk was phosphorylated on serine by Pak2.
|
The effects of phosphorylation of Syk by Pak2 were examined by using Val5-angiotensin II as the substrate. As shown in Fig. 5, phosphorylation of angiotensin was increased when Syk was incubated with Cdc42-activated Pak2. An increase of 1.6-fold was observed when 32P incorporation into Syk was analyzed by thin-layer electrophoresis (Fig. 5A). This was consistent with the results obtained by precipitation of phosphorylated Syk on filter paper (Fig. 5B).
|
|
Hyperosmotic stress induces the association of Pak2 with Syk in the perinuclear region. Endogenous Pak2 is present in both the cytosolic and particulate fractions in mouse fibroblast 3T3-L1 cells. Moreover, recent findings demonstrate that localization of Pak2 in the endoplasmic reticulum is required for the induction of cytostasis (7). Therefore, we examined the intracellular localization of Pak2 and Syk in COS-7 cells. Immunohistochemical analysis using confocal microscopy confirmed the association of Pak2 and Syk (Fig. 7). Pak2 and Syk were concentrated in a region near the nucleus and were also located elsewhere in the cytosolic region, but not in the nucleus (Fig. 7, top panels). Sorbitol treatment resulted in shrinkage of the cells and an increase in the association of Pak2 with Syk in the perinuclear region (Fig. 7, bottom panels).
|
|
|
|
-tubulin (Fig. 11A). Densitometric analysis revealed that protein expression was suppressed by 90 or 70% with the Pak2(17-35) or Pak2(472-490) siRNA, respectively. This demonstrated that Pak2 is essential for hyperosmolarity-induced activation of JNK in B cells. In addition to the siRNA, overexpression of the dominant-negative form of Pak2 (T402A) resulted in the suppression of sorbitol-mediated activation of JNK (Fig. 11B) (7). Moreover, overexpression of the kinase-inactive form of Syk suppressed sorbitol-mediated activation of JNK (Fig. 11C). Thus, these results suggest that both Pak2 and its associating protein Syk are critical in B cells for hyperosmolarity-mediated physiological responses. Finally, the effect of Pak2 siRNA on hyperosmolarity-induced activation of endogenous Syk was examined (Fig. 11D). As shown, suppression of Pak2 directly inhibits phosphorylation of Syk. Phosphorylation of Tyr525 and Tyr526 in the activation loop of Syk is correlated with the activation of Syk (17, 41). These results demonstrated that Pak2 is required for the activation of Syk by sorbitol and that the Pak2-Syk pathway is involved in the hyperosmolar response. The data identify a new pathway for activation of the stress-activated protein kinase JNK through Cdc42.
|
| DISCUSSION |
|---|
|
|
|---|
We have demonstrated that Pak2 is upstream of Syk in cellular signaling and that Pak2 and Syk cooperate in the hyperosmotic stress-mediated activation of JNK. Activation of JNK leads to the activation of various transcription factors and expression of specific genes (5). We utilized sorbitol-mediated activation of JNK as a parameter of Syk kinase activity in cellular signaling. Our results show that sorbitol-mediated activation of endogenous JNK is enhanced by the overexpression of Syk (Fig. 8). Expression of the kinase-inactive form of Syk suppresses sorbitol-mediated activation of JNK (Fig. 11). Furthermore, coexpression of WT Pak2 and Cdc42 with Syk dramatically stimulates JNK activation, as a result of the association of Pak2 and Syk, and elevates Syk kinase activity. The suppression of Pak2 by the specific siRNA results in the inhibition of sorbitol-mediated activation of both Syk and JNK (Fig. 11). We have not tested whether caspase 3 cleavage products of Pak2 could associate with Syk and stimulate its kinase activity. In our experimental system, osmotic stress did not cause any increase in the caspase cleavage of Pak2 in COS-7 cells (data not shown). It remains unknown whether the extreme stress that results in cleavage and activation of Pak2 could induce the association of Pak2 with Syk to stimulate JNK activity. Collectively, Syk could be responsible for osmotic stress-mediated JNK activation in mammalian cells, cooperating with Pak2 and Rho family GTP binding proteins. Activation of Syk in response to osmotic stress requires the interaction with Pak2.
Pak2 has been shown to have cytostatic properties, as shown by microinjection of Pak2 into early frog embryos (27) and overexpression of Pak2 in COS-7 and HEK 293T cells (7). Activation of Pak2 by moderate cell stress inhibits cell division, resulting in inhibition of cell growth, whereas high levels of stress or irreparable damage results in cell death. Both Pak2 and Syk are activated in response to oxidative stress. Syk activation by moderate oxidative stress leads to the activation of the PI 3-kinase-Akt survival pathway (34). On the other hand, extreme oxidative stress induces Syk-dependent phospholipase C-
activation, which accelerates oxidative stress-mediated apoptosis (34).
Both Pak2 and Syk were originally isolated as cytosolic kinases. Various cellular ligands induce the translocation of these enzymes to the perinuclear region. Active Pak2, but not the inactive enzyme, is tightly associated with the endoplasmic reticulum, and the amount of Pak2 associated with the endoplasmic reticulum is significantly enhanced in cells that are stressed and/or not dividing (7). In COS-7 cells, Pak2 and Syk are primarily cytosolic, and sorbitol treatment increases translocation of both kinases to the perinuclear region (Fig. 7). Unlike that of c-Abl, tyrosine phosphorylation of Pak2 by Syk did not result in an accumulation of inactive Pak2 or inhibit its protein turnover through the proteasome degradation pathway (Fig. 1). It is suggested that Pak2 and Syk transmit the activating signals to the downstream molecules from the perinuclear region. In immune receptor signaling, Syk translocates to the plasma membrane to interact with receptors in the glycolipid-enriched microdomain (33). Syk phosphorylates Vav, a guanine nucleotide exchange factor of Rac1, to regulate calcium mobilization and transcription of cytokine messages (1, 6, 19). In T cells, activation of Rac1 and subsequently Pak1 requires a Syk family PTK (16). Our findings demonstrate that there is a distinct distribution and function of Syk that is different from that established in the immune cells.
It is interesting that although both ERK and JNK are downstream of Syk in the immune receptor signaling, only JNK is activated in nonhematopoietic cells (12). In breast cancer cells, induction of Syk protein results in a suppression of tumor cell proliferation resulting from the abnormalities of cell division (14). Perhaps Pak2 and Syk cooperate to stimulate the transcription and translation of both proapoptotic and antiapoptotic proteins which are downstream of JNK.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Asahi, M., Y. Tanaka, S. Qin, M. Tsubokawa, K. Sada, Y. Minami, and H. Yamamura. 1995. Cyclic AMP-elevating agents negatively regulate the activation of p72syk in N-formyl-methionyl-leucyl-phenylalanine receptor signaling. Biochem. Biophys. Res. Commun. 212:887-893.[CrossRef][Medline]
3. Bagrodia, S., and R. A. Cerione. 1999. Pak to the future. Trends Cell Biol. 9:350-355.[CrossRef][Medline]
4. Coopman, P. J., M. T. Do, M. Barth, E. T. Bowden, A. J. Hayes, E. Basyuk, J. K. Blancato, P. R. Vezza, S. W. McLeskey, P. H. Mangeat, and S. C. Mueller. 2000. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742-747.[CrossRef][Medline]
5. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.[CrossRef][Medline]
6. Deckert, M., S. Tartare-Deckert, C. Couture, T. Mustelin, and A. Altman. 1996. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591-604.[CrossRef][Medline]
7. Huang, Z., J. Ling, and J. A. Traugh. 2003. Localization of p21-activated protein kinase gamma-PAK/Pak2 in the endoplasmic reticulum is required for induction of cytostasis. J. Biol. Chem. 278:13101-13109.
8. Inoue, O., K. Suzuki-Inoue, W. L. Dean, J. Frampton, and S. P. Watson. 2003. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J. Cell Biol. 160:769-780.
9. Jacinto, E., G. Werlen, and M. Karin. 1998. Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes. Immunity 8:31-41.[CrossRef][Medline]
10. Jakobi, R., C. J. Chen, P. T. Tuazon, and J. A. Traugh. 1996. Molecular cloning and sequencing of the cytostatic G protein-activated protein kinase PAK I. J. Biol. Chem. 271:6206-6211.
11. Jakobi, R., E. Moertl, and M. A. Koeppel. 2001. p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J. Biol. Chem. 276:16624-16634.
12. Jiang, A., A. Craxton, T. Kurosaki, and E. A. Clark. 1998. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J. Exp. Med. 188:1297-1306.
13. Keshvara, L. M., C. C. Isaacson, T. M. Yankee, R. Sarac, M. L. Harrison, and R. L. Geahlen. 1998. Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling. J. Immunol. 161:5276-5283.
14. Kimura, T., H. Sakamoto, E. Appella, and R. P. Siraganian. 1996. Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16:1471-1478.[Abstract]
15. Knaus, U. G., and G. M. Bokoch. 1998. The p21Rac/Cdc42-activated kinases (PAKs). Int. J. Biochem. Cell Biol. 30:857-862.[CrossRef][Medline]
16. Ku, G. M., D. Yablonski, E. Manser, L. Lim, and A. Weiss. 2001. A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT. EMBO J. 20:457-465.[CrossRef][Medline]
17. Kurosaki, T., S. A. Johnson, L. Pao, K. Sada, H. Yamamura, and J. C. Cambier. 1995. Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J. Exp. Med. 182:1815-1823.
18. Lee, N., H. MacDonald, C. Reinhard, R. Halenbeck, A. Roulston, T. Shi, and L. T. Williams. 1997. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc. Natl. Acad. Sci. USA 94:13642-13647.
19. Manetz, T. S., C. Gonzalez-Espinosa, R. Arudchandran, S. Xirasagar, V. Tybulewicz, and J. Rivera. 2001. Vav1 regulates phospholipase C
activation and calcium responses in mast cells. Mol. Cell. Biol. 21:3763-3774.
20. Mitsui, N., R. Inatome, S. Takahashi, Y. Goshima, H. Yamamura, and S. Yanagi. 2002. Involvement of Fes/Fps tyrosine kinase in semaphorin 3A signaling. EMBO J. 21:3274-3285.[CrossRef][Medline]
21. Poole, A., J. M. Gibbins, M. Turner, M. J. van Vugt, J. G. van de Winkel, T. Saito, V. L. Tybulewicz, and S. P. Watson. 1997. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 16:2333-2341.[CrossRef][Medline]
22. Qin, S., Y. Minami, M. Hibi, T. Kurosaki, and H. Yamamura. 1997. Syk-dependent and -independent signaling cascades in B cells elicited by osmotic and oxidative stress. J. Biol. Chem. 272:2098-2103.
23. Renkema, G. H., A. Manninen, and K. Saksela. 2001. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J. Virol. 75:2154-2160.
24. Roig, J., Z. Huang, C. Lytle, and J. A. Traugh. 2000. p21-activated protein kinase gamma-PAK is translocated and activated in response to hyperosmolarity. Implication of Cdc42 and phosphoinositide 3-kinase in a two-step mechanism for gamma-PAK activation. J. Biol. Chem. 275:16933-16940.
25. Roig, J., and J. A. Traugh. 1999. p21-activated protein kinase gamma-PAK is activated by ionizing radiation and other DNA-damaging agents. Similarities and differences to alpha-PAK. J. Biol. Chem. 274:31119-31122.
26. Roig, J., P. T. Tuazon, P. A. Zipfel, A. M. Pendergast, and J. A. Traugh. 2000. Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK. Proc. Natl. Acad. Sci. USA 97:14346-14351.
27. Rooney, R. D., P. T. Tuazon, W. E. Meek, E. J. Carroll, J. J. Hagen, E. L. Gump, C. A. Monnig, T. Lugo, and J. A. Traugh. 1996. Cleavage arrest of early frog embryos by the G protein-activated protein kinase PAK I. J. Biol. Chem. 271:21498-21504.
28. Rudel, T., and G. M. Bokoch. 1997. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276:1571-1574.
29. Sada, K., S. M. S. Miah, K. Maeno, S. Kyo, X. Qu, and H. Yamamura. 2002. Regulation of Fcepsilon RI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood 100:2138-2144.
30. Sada, K., Y. Minami, and H. Yamamura. 1997. Relocation of Syk protein-tyrosine kinase to the actin filament network and subsequent association with Fak. Eur. J. Biochem. 248:827-833.[Medline]
31. Sada, K., T. Takano, S. Yanagi, and H. Yamamura. 2001. Structure and function of Syk protein-tyrosine kinase. J. Biochem. (Tokyo) 130:177-186.
32. Sada, K., J. Zhang, and R. P. Siraganian. 2000. Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J. Immunol. 164:338-344.
33. Sada, K., J. Zhang, and R. P. Siraganian. 2001. SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for FcepsilonRI signaling. Blood 97:1352-1359.
34. Takano, T., K. Sada, and H. Yamamura. 2002. Role of protein-tyrosine kinase Syk in oxidative stress signaling in B cells. Antioxid. Redox Signal. 4:533-540.[CrossRef][Medline]
35. Tuazon, P. T., M. Chinwah, and J. A. Traugh. 1998. Autophosphorylation and protein kinase activity of p21-activated protein kinase gamma-PAK are differentially affected by magnesium and manganese. Biochemistry 37:17024-17029.[CrossRef][Medline]
36. Tuazon, P. T., W. C. Spanos, E. L. Gump, C. A. Monnig, and J. A. Traugh. 1997. Determinants for substrate phosphorylation by p21-activated protein kinase (gamma-PAK). Biochemistry 36:16059-16064.[CrossRef][Medline]
37. Turner, M., E. Schweighoffer, F. Colucci, J. P. Di Santo, and V. L. Tybulewicz. 2000. Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol. Today 21:148-154.[CrossRef][Medline]
38. Walter, B. N., Z. Huang, R. Jakobi, P. T. Tuazon, E. S. Alnemri, G. Litwack, and J. A. Traugh. 1998. Cleavage and activation of p21-activated protein kinase gamma-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. J. Biol. Chem. 273:28733-28739.
39. Wolf, D., V. Witte, B. Laffert, K. Blume, E. Stromer, S. Trapp, P. d'Aloja, A. Schurmann, and A. S. Baur. 2001. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7:1217-1224.[CrossRef][Medline]
40. Yanagi, S., R. Inatome, J. Ding, H. Kitaguchi, V. L. Tybulewicz, and H. Yamamura. 2001. Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice. Blood 98:2869-2871.
41. Zhang, J., M. L. Billingsley, R. L. Kincaid, and R. P. Siraganian. 2000. Phosphorylation of Syk activation loop tyrosines is essential for Syk function. An in vivo study using a specific anti-Syk activation loop phosphotyrosine antibody. J. Biol. Chem. 275:35442-35447.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. |
|---|